Cystathionine beta synthase gene dose dependent vascular remodeling in murine model of hyperhomocysteinemia. - Wikidata - wikimedia - TriplyDB

Cystathionine beta synthase gene dose dependent vascular remodeling in murine model of hyperhomocysteinemia.

Cystathionine beta synthase gene dose dependent vascular remodeling in murine model of hyperhomocysteinemia.

http://www.wikidata.org/entity/Q35220296

about

Curcumin-primed exosomes mitigate endothelial cell dysfunction during hyperhomocysteinemia.Role of microRNA29b in blood-brain barrier dysfunction during hyperhomocysteinemia: an epigenetic mechanism.Epigenetic regulation of aortic remodeling in hyperhomocysteinemia.The therapeutic potential of cystathionine β-synthetase/hydrogen sulfide inhibition in cancer Folic acid mitigates angiotensin-II-induced blood pressure and renal remodeling.Hyperhomocysteinemia attenuates angiogenesis through reduction of HIF-1α and PGC-1α levels in muscle fibers during hindlimb ischemia The link between angiotensin II-mediated anxiety and mood disorders with NADPH oxidase-induced oxidative stress.Increased endogenous H2S generation by CBS, CSE, and 3MST gene therapy improves ex vivo renovascular relaxation in hyperhomocysteinemia.Vascular Remodeling, Oxidative Stress, and Disrupted PPARγ Expression in Rats of Long-Term Hyperhomocysteinemia with Metabolic Disturbance.Hydrogen sulfide improves postischemic neoangiogenesis in the hind limb of cystathionine-β-synthase mutant mice via PPAR-γ/VEGF axis

P2860

Q33821425-6130DFA6-E9B2-4E57-9AC2-8ED510E7A99F Q33851501-D8CA5AB7-D18E-4E36-AB69-D6A3501C65E8 Q33913216-901163BA-338D-4992-9893-0B39AFBD0AE0 Q35016080-8EA81B4F-BA3E-4A68-85F2-E382180A62D7 Q35080666-DD3FD8B0-3F4B-4914-A069-8A37A37EF8A4 Q35105501-8ECEE6A6-63BB-409C-8D35-FB420F50A9EF Q35853134-64150EF9-FEA4-4C94-9E3E-284AD91BCB5E Q36114692-18ABC27E-D068-4381-B53C-10BBE33E9DED Q51244984-AC6D1FCA-36AD-4D3B-B82E-9155ADAA88A6 Q58770377-06588E71-2F99-4191-ACD6-AD204C59599A

P2860

Cystathionine beta synthase gene dose dependent vascular remodeling in murine model of hyperhomocysteinemia.

http://www.wikidata.org/entity/Q35220296

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Cystathionine beta synthase ge ...... model of hyperhomocysteinemia.

@ast

Cystathionine beta synthase ge ...... model of hyperhomocysteinemia.

@en

type

label

Cystathionine beta synthase ge ...... model of hyperhomocysteinemia.

@ast

Cystathionine beta synthase ge ...... model of hyperhomocysteinemia.

@en

prefLabel

Cystathionine beta synthase ge ...... model of hyperhomocysteinemia.

@ast

Cystathionine beta synthase ge ...... model of hyperhomocysteinemia.

@en

P1433

Q35220296-180B5B14-5DDE-4337-A3ED-DB1E5E52A859

P1476

Q35220296-9A1DBEB2-EBDE-4076-8602-054ED715686C

P2093

Q35220296-61CFFF4E-E4FE-4121-A5F8-C986CFF10B81

Q35220296-764B320C-61A0-4E76-8294-6E91B32EA70C

Q35220296-76A0827A-C37C-4B9B-B86E-FA645E436C3A

Q35220296-82983C51-FAA2-4288-919A-E6EF2BA87025

Q35220296-B1CF6281-276F-46B3-AA93-B1AE60947204

Q35220296-CA2B4901-C7ED-43A3-8576-185E5119E326

P2860

Q35220296-0C24681C-65BA-48CB-9214-AF33842FDD1E

Q35220296-1D1D3DF8-5F12-450C-A32B-2282A1D00D6E

Q35220296-27437233-CFA0-428B-BD28-B03054B956B5

Q35220296-41420372-F624-43CB-8F30-C8F452D5BCF9

Q35220296-41BBE456-3A6D-48BE-AC48-537CC97D2E58

Q35220296-4699A2C4-3A87-4F49-9C29-1AA494A8B553

Q35220296-484D11BC-4F0A-47A5-8036-5314659E22CC

Q35220296-4A251882-2CEE-4D9D-BC01-DF92C611FD2B

Q35220296-527AE2C4-FC6F-4B7D-88BE-3DC6691D183C

Q35220296-52A62A76-B8CA-4F86-8A72-D4EDF88396BC

P304

Q35220296-077196F7-CD58-4C3A-B1A6-C2B0B7761CAB

P31

Q35220296-A76658AF-1822-4415-AB6B-F990990FF188

P433

Q35220296-09C077B5-9468-451D-B616-BE9369FAA3F1

P478

Q35220296-453EE8C9-0EB6-40B7-BD6D-D73C16BEF33B

P577

Q35220296-9A6CAE26-296E-4C1D-8069-B24AC642D1E3

P698

Q35220296-07A7536F-1CA4-4BCF-A9ED-4C27B0D88245

P932

Q35220296-C3252223-40CF-4028-950B-327AC276DD1F

P1433

International journal of physiology, pathophysiology and pharmacology

P1476

Cystathionine beta synthase ge ...... model of hyperhomocysteinemia

@en

P2093

Alexander Ovechkin

http://www.w3.org/2001/XMLSchema#string

Natia Qipshidze

http://www.w3.org/2001/XMLSchema#string

Neetu Tyagi

http://www.w3.org/2001/XMLSchema#string

Suresh C Tyagi

http://www.w3.org/2001/XMLSchema#string

Utpal Sen

http://www.w3.org/2001/XMLSchema#string

Walter Rodriguez

http://www.w3.org/2001/XMLSchema#string

P2860

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma

A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group

Peroxynitrite reductase activity of bacterial peroxiredoxins

Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia

Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia

Ppargamma2 is a key driver of longevity in the mouse.

The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells.

Endothelial dysfunction: from physiology to therapy.

Homocyst(e)ine and heart disease: pathophysiology of extracellular matrix.

The peroxisome proliferator-activated receptor(PPARgamma) as a regulator of monocyte/macrophage function.

P304

210-222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21941612

http://www.w3.org/2001/XMLSchema#string

P932

3175747

http://www.w3.org/2001/XMLSchema#string